【New Stock IPO】InPace Pharmaceuticals 7630 dark pool once surged nearly 1.6 times; one lot could make up to 6,380 yuan. The allocation results are out: by placing orders of 3,000 lots with a total application amount of 13.18 million yuan to only be considered stable, with the “head hammer” error occurring at up to 3 lots.

Biotechnology Company Innate Pharma (Listing Number: 07630) Will be listed on May 13, with dark pool trading on Tuesday. Among the three major trading platforms, Innate Pharma’s dark pool initial market saw a high of 52 HKD on Futu, which is 159% higher than the IPO price of 20.1 HKD, with a profit of 6,380 HKD on a 200-share lot.

Brokerages announced the allocation results to investors on Monday (11th). Reports indicate that retail investors need to subscribe for 600k shares (3,000 lots, worth about 13.18 million HKD) to guarantee a successful bid, securing 1 lot of 200 shares. As for the “top-up” subscription of 600k shares (about 46.11 million HKD), they can receive 2 to 3 lots (400 to 600 shares). The initial allocation results for Zhentai Technology 7666, which also listed on the same day, show that the “top-up” can be up to 4 lots.

Innate Pharma is priced at 20.1 HKD per share, close to the lower end of the IPO range of 19.75 to 21.75 HKD. With an issuance of 2.1M shares, it aims to raise 844 million HKD. The entry fee for one lot is 4,393.9 HKD. Goldman Sachs and China International Capital Corporation are joint sponsors.

Follow news on new stocks, visit 【New Stock IPO】

Open market trading: buy and sell

Is the global focus on the “Xi-Trump Meeting” causing the stock market to rally? Do Hong Kong stocks still rely on Alibaba and Tencent’s earnings?